- Home
- DDI vs TBPH Comparison
DDI vs TBPH Comparison
Compare DDI & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDI
- TBPH
- Stock Information
- Founded
- DDI 2008
- TBPH 2013
- Country
- DDI South Korea
- TBPH United States
- Employees
- DDI N/A
- TBPH N/A
- Industry
- DDI EDP Services
- TBPH Biotechnology: Pharmaceutical Preparations
- Sector
- DDI Technology
- TBPH Health Care
- Exchange
- DDI Nasdaq
- TBPH Nasdaq
- Market Cap
- DDI 493.6M
- TBPH 464.5M
- IPO Year
- DDI 2021
- TBPH N/A
- Fundamental
- Price
- DDI $9.89
- TBPH $9.02
- Analyst Decision
- DDI Strong Buy
- TBPH Buy
- Analyst Count
- DDI 4
- TBPH 4
- Target Price
- DDI $21.50
- TBPH $13.75
- AVG Volume (30 Days)
- DDI 20.8K
- TBPH 195.6K
- Earning Date
- DDI 05-07-2025
- TBPH 05-12-2025
- Dividend Yield
- DDI N/A
- TBPH N/A
- EPS Growth
- DDI N/A
- TBPH N/A
- EPS
- DDI 2.50
- TBPH N/A
- Revenue
- DDI $341,330,000.00
- TBPH $64,381,000.00
- Revenue This Year
- DDI $1.98
- TBPH $39.34
- Revenue Next Year
- DDI $2.43
- TBPH $3.63
- P/E Ratio
- DDI $3.96
- TBPH N/A
- Revenue Growth
- DDI N/A
- TBPH 12.12
- 52 Week Low
- DDI $8.56
- TBPH $7.44
- 52 Week High
- DDI $18.21
- TBPH $10.90
- Technical
- Relative Strength Index (RSI)
- DDI 48.55
- TBPH 35.49
- Support Level
- DDI $9.56
- TBPH $9.05
- Resistance Level
- DDI $10.17
- TBPH $9.55
- Average True Range (ATR)
- DDI 0.34
- TBPH 0.24
- MACD
- DDI 0.02
- TBPH -0.06
- Stochastic Oscillator
- DDI 52.33
- TBPH 3.61
About DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. Its market opportunity includes casual gaming globally, which includes slots, puzzles, cards, match three, and other similar games. Within the social casino segment of casual gaming, which includes free-to-play online slots, poker, table games, and bingo. Other games developed by the company are DoubleDown Fort, DoubleDown Classic, and Ellen's Road to Riches. The company has a presence in the international market, and it derives a majority of its revenue from the United States of America.
About TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).